Back to Search Start Over

Fluconazole treatment of candidal infections caused by non-albicans Candida species.

Authors :
van 't Wout JW
Source :
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 1996 Mar; Vol. 15 (3), pp. 238-42.
Publication Year :
1996

Abstract

Fluconazole is an effective alternative to amphotericin B for the treatment of serious infections caused by Candida albicans. Through a literature survey of candidal infections caused by non-albicans Candida spp., 43 cases treated with fluconazole were found. The most common causative organisms were Candida parapsilosis (14 patients), Candida glabrata (12 patients), and Candida tropicalis (11 patients). The dose of fluconazole varied from 50 to 400 mg daily. The median duration of treatment was 21 days. Overall efficacy was 77%. The efficacy against the various species was 93% for Candida parapsilosis, 50% for Candida glabrata, and 82% for Candida tropicalis. In conclusion, fluconazole is effective against the most common non-albicans Candida spp., although higher doses may be required for infections caused by Candida glabrata. Infections caused by Candida krusei should not be treated with fluconazole.

Details

Language :
English
ISSN :
0934-9723
Volume :
15
Issue :
3
Database :
MEDLINE
Journal :
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Publication Type :
Academic Journal
Accession number :
8740860
Full Text :
https://doi.org/10.1007/BF01591361